Page last updated: 2024-10-27

flurbiprofen and Neurodevelopmental Disorders

flurbiprofen has been researched along with Neurodevelopmental Disorders in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doi, M1
Seki, M1
Furuichi, Y1

Other Studies

1 other study available for flurbiprofen and Neurodevelopmental Disorders

ArticleYear
Psychiatric adverse reaction to non-steroidal anti-inflammatory drugs in a child.
    Pediatrics international : official journal of the Japan Pediatric Society, 2019, Volume: 61, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Drug Therapy, Combination; Femal

2019